Tumours were classified as PG or NPG carcinomas, and these groups were compared concerning patient age, gender, clinical stage, tumour size, vascular invasion, tumour location, tumour differentiation, APC mutation, Ki-ras mutation, p53 mutation, and MSI. This evidence concerns the gene TP53 and carcinoma.